REPORTS

Let’s Pullulate and Expand Your Business

Cardiac Markers Market - Global Professional Analysis and Forecast to 2026

Nov 07, 2019  |  177 PAGES  |  REPORT CODE: CMM230787
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Cardiac Markers market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.0% during the forecast period.

This report presents the market size and development trends by detailing the Cardiac Markers market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Cardiac Markers market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Cardiac Markers industry and will help you to build a panoramic view of the industrial development.

Cardiac Markers Market, By Type:

  • Troponin I

  • Creatine Kinase

  • Lactate dehydrogenase

  • Aspartate transaminase

  • Myoglobin

  • Ischemia-modified albumin

  • Pro-brain natriuretic peptide

  • Glycogen phosphorylase isoenzyme BB

  • Other

Cardiac Markers Market, By Application:

  • End-User 1

  • End-User 2

  • End-User 3

Some of the leading players are as follows:

  • Boston Scientific

  • DiaDexus

  • Randox Laboratories

  • Biomerieux

  • BD

  • Mitsubishi

  • Siemens

  • AniBiotech

  • Alere

  • Trinity Biotech

  • Axis-Shield

  • Nanomix

  • Thermo Fisher

  • Sierra Resources

  • BG

  • Abbott

  • LifeSign

  • Singulex

  • Radiometer

  • Roche

  • Critical Diagnostics

  • Response Biomedical

  • Beckman Coulter

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Cardiac Markers Market: Technology Type Analysis

  • 4.1 Cardiac Markers Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Cardiac Markers Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Troponin I

    • 4.3.2 Creatine Kinase

    • 4.3.3 Lactate dehydrogenase

    • 4.3.4 Aspartate transaminase

    • 4.3.5 Myoglobin

    • 4.3.6 Ischemia-modified albumin

    • 4.3.7 Pro-brain natriuretic peptide

    • 4.3.8 Glycogen phosphorylase isoenzyme BB

    • 4.3.9 Other

5 Cardiac Markers Market: Product Analysis

  • 5.1 Cardiac Markers Product Market Share Analysis, 2018 & 2026

  • 5.2 Cardiac Markers Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Cardiac Markers Market: Application Analysis

  • 6.1 Cardiac Markers Application Market Share Analysis, 2018 & 2026

  • 6.2 Cardiac Markers Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 End-User 1

    • 6.3.2 End-User 1

    • 6.3.3 End-User 3

7 Cardiac Markers Market: Regional Analysis

  • 7.1 Cardiac Markers Regional Market Share Analysis, 2018 & 2026

  • 7.2 Cardiac Markers Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Boston Scientific

    • 9.1.1 Boston Scientific Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 DiaDexus

    • 9.2.1 DiaDexus Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Randox Laboratories

    • 9.3.1 Randox Laboratories Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Biomerieux

    • 9.4.1 Biomerieux Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 BD

    • 9.5.1 BD Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Mitsubishi

    • 9.6.1 Mitsubishi Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Siemens

    • 9.7.1 Siemens Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 AniBiotech

    • 9.8.1 AniBiotech Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Alere

    • 9.9.1 Alere Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Trinity Biotech

    • 9.10.1 Trinity Biotech Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Axis-Shield

    • 9.11.1 Axis-Shield Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Nanomix

    • 9.12.1 Nanomix Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Thermo Fisher

    • 9.13.1 Thermo Fisher Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Sierra Resources

    • 9.14.1 Sierra Resources Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 BG

    • 9.15.1 BG Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 Abbott

    • 9.16.1 Abbott Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 LifeSign

    • 9.17.1 LifeSign Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

  • 9.18 Singulex

    • 9.18.1 Singulex Company overview

    • 9.18.2 Financial performance

    • 9.18.3 Product benchmarking

    • 9.18.4 Strategic initiatives

    • 9.18.5 SWOT analysis

  • 9.19 Radiometer

    • 9.19.1 Radiometer Company overview

    • 9.19.2 Financial performance

    • 9.19.3 Product benchmarking

    • 9.19.4 Strategic initiatives

    • 9.19.5 SWOT analysis

  • 9.20 Roche

    • 9.20.1 Roche Company overview

    • 9.20.2 Financial performance

    • 9.20.3 Product benchmarking

    • 9.20.4 Strategic initiatives

    • 9.20.5 SWOT analysis

  • 9.21 Critical Diagnostics

    • 9.21.1 Critical Diagnostics Company overview

    • 9.21.2 Financial performance

    • 9.21.3 Product benchmarking

    • 9.21.4 Strategic initiatives

    • 9.21.5 SWOT analysis

  • 9.22 Response Biomedical

    • 9.22.1 Response Biomedical Company overview

    • 9.22.2 Financial performance

    • 9.22.3 Product benchmarking

    • 9.22.4 Strategic initiatives

    • 9.22.5 SWOT analysis

  • 9.23 Beckman Coulter

    • 9.23.1 Beckman Coulter Company overview

    • 9.23.2 Financial performance

    • 9.23.3 Product benchmarking

    • 9.23.4 Strategic initiatives

    • 9.23.5 SWOT analysis

 

The List of Tables and Figures (Totals 75 Figures and 124 Tables)

  • Figure Troponin I Cardiac Markers market, 2015 - 2026 (USD Million)

  • Figure Creatine Kinase Cardiac Markers market, 2015 - 2026 (USD Million)

  • Figure Lactate dehydrogenase Cardiac Markers market, 2015 - 2026 (USD Million)

  • Figure Aspartate transaminase Cardiac Markers market, 2015 - 2026 (USD Million)

  • Figure Myoglobin Cardiac Markers market, 2015 - 2026 (USD Million)

  • Figure Ischemia-modified albumin Cardiac Markers market, 2015 - 2026 (USD Million)

  • Figure Pro-brain natriuretic peptide Cardiac Markers market, 2015 - 2026 (USD Million)

  • Figure Glycogen phosphorylase isoenzyme BB Cardiac Markers market, 2015 - 2026 (USD Million)

  • Figure Other Cardiac Markers market, 2015 - 2026 (USD Million)

  • Figure End-User 1 market, 2015 - 2026 (USD Million)

  • Figure End-User 2 market, 2015 - 2026 (USD Million)

  • Figure End-User 3 market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Cardiac Markers market, by country, 2015 - 2026 (USD Million)

  • Table North America Cardiac Markers market, by type, 2015 - 2026 (USD Million)

  • Table North America Cardiac Markers market, by product, 2015 - 2026 (USD Million)

  • Table North America Cardiac Markers market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Cardiac Markers market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Cardiac Markers market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Cardiac Markers market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Cardiac Markers market, by type, 2015 - 2026 (USD Million)

  • Table Canada Cardiac Markers market, by product, 2015 - 2026 (USD Million)

  • Table Canada Cardiac Markers market, by application, 2015 - 2026 (USD Million)

  • Table Europe Cardiac Markers market, by country, 2015 - 2026 (USD Million)

  • Table Europe Cardiac Markers market, by type, 2015 - 2026 (USD Million)

  • Table Europe Cardiac Markers market, by product, 2015 - 2026 (USD Million)

  • Table Europe Cardiac Markers market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Cardiac Markers market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Cardiac Markers market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Cardiac Markers market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Cardiac Markers market, by type, 2015 - 2026 (USD Million)

  • Table Germany Cardiac Markers market, by product, 2015 - 2026 (USD Million)

  • Table Germany Cardiac Markers market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Cardiac Markers market, by type, 2015 - 2026 (USD Million)

  • Table France Cardiac Markers market, by product, 2015 - 2026 (USD Million)

  • Table France Cardiac Markers market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Cardiac Markers market, by type, 2015 - 2026 (USD Million)

  • Table Italy Cardiac Markers market, by product, 2015 - 2026 (USD Million)

  • Table Italy Cardiac Markers market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Cardiac Markers market, by type, 2015 - 2026 (USD Million)

  • Table Spain Cardiac Markers market, by product, 2015 - 2026 (USD Million)

  • Table Spain Cardiac Markers market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Cardiac Markers market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Cardiac Markers market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Cardiac Markers market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Cardiac Markers market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Cardiac Markers market, by type, 2015 - 2026 (USD Million)

  • Table China Cardiac Markers market, by product, 2015 - 2026 (USD Million)

  • Table China Cardiac Markers market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Cardiac Markers market, by type, 2015 - 2026 (USD Million)

  • Table Japan Cardiac Markers market, by product, 2015 - 2026 (USD Million)

  • Table Japan Cardiac Markers market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Cardiac Markers market, by type, 2015 - 2026 (USD Million)

  • Table India Cardiac Markers market, by product, 2015 - 2026 (USD Million)

  • Table India Cardiac Markers market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Cardiac Markers market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Cardiac Markers market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Cardiac Markers market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Cardiac Markers market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Cardiac Markers market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Cardiac Markers market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Cardiac Markers market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Cardiac Markers market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Cardiac Markers market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Cardiac Markers market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Cardiac Markers market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Cardiac Markers market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Cardiac Markers market, by application, 2015 - 2026 (USD Million)

  • Table MEA Cardiac Markers market, by country, 2015 - 2026 (USD Million)

  • Table MEA Cardiac Markers market, by type, 2015 - 2026 (USD Million)

  • Table MEA Cardiac Markers market, by product, 2015 - 2026 (USD Million)

  • Table MEA Cardiac Markers market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Cardiac Markers market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Cardiac Markers market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Cardiac Markers market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Cardiac Markers market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Cardiac Markers market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Cardiac Markers market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Boston Scientific Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table DiaDexus Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Randox Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Biomerieux Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table BD Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mitsubishi Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Siemens Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AniBiotech Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Alere Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Trinity Biotech Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Axis-Shield Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Nanomix Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Thermo Fisher Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sierra Resources Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table BG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbott Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table LifeSign Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Singulex Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Radiometer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Roche Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Critical Diagnostics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Response Biomedical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Beckman Coulter Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top